Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Observation × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Endometrial Neoplasms 13 Colorectal Neoplasms 12 Stomach Neoplasms 11 Lung Neoplasms 11 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cisplatin 11 Everolimus 10 Nivolumab 7 Etoposide 7 Temozolomide 5 Ipilimumab 5 Carboplatin 5 atezolizumab 4 Irinotecan 4 pembrolizumab 3 lutetium Lu 177 dotatate 3 avelumab 3 Paclitaxel 3 Fluorouracil 3 Capecitabine 3 Bevacizumab 3 surufatinib 2 sintilimab 2 dostarlimab 2 belinostat 2 azaspirane 2 Topotecan 2 Positron Emission Tomography Computed Tomography 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 IFL protocol 2 Fluorodeoxyglucose F18 2 EC regimen 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07192991 2025-09-25

NECTARINE

Latin American Cooperative Oncology Group

Not yet recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡